Phase III KATHERINE trial crossed early reporting boundary and met its primary endpoint
A phase III clinical trial showed that neoadjuvant chemotherapy and trastuzumab reduced the risk of recurrence of HER2-positive early-stage breast cancer...
List view / Grid view
News
Trastuzumab taken with carvedilol leads to less heart damage
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
Rivaroxaban reduced blood clots and related death in cancer patients
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
Discovery to save more women in childbirth from postpartum hemorrhaging
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year...
‘Elastic’ contrast protein for more accurate imaging
Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)...
Global 2-year trial reports on CAR-T therapy to treat DLBCL
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
Cardiac cells integrated into microneedle patches could treat heart attacks
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
Metrohm USA contributes to global monograph modernisation initiative
Metrohm USA is proud to continue its productive collaboration with USP on a global initiative to modernise monographs that have traditionally featured wet chemistry methods...
Nanoscale blood test could discover more from cancer patients’ blood
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
New brain circuits formed for motor function after Parkinson’s therapy
A gene therapy called AAV2-GAD has been associated with improved motor function, leading to researchers looking at its use in an upcoming Phase III trial...
Lanadelumab effective in reducing hereditary angioedema attacks
Results of a clinical trial has led to the FDA approval of a monoclonal antibody drug called lanadelumab, to treat hereditary angioedema attacks...
Pulsed radiofrequency could relieve sciatica and back pain
The use of pRF also could improve outcomes for patients set to receive corticosteroid injections, and was found to be minimally invasive with good results...
Canada clinical trial on personalised medicine for prostate cancer
A clinical trial could be the world's first to look at personalised medicine in prostate cancer, with patients taking a therapy based on their DNA markers...
Protection against yellow fever provided by fractional-dose vaccination
Researchers at Leiden University Medical Center have identified how fractional-dose yellow fever vaccinations protect against the condition for ten years...
Using graphene as a tunable ion filter
NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems...
